Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    NCT00425815
Show Display Options
Download search resultsDownload the search results for:
NCT00425815 (1 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Withdrawn Org 24448 (Ampakine) for Cognitive Deficits in Schizophrenia
Condition: Schizophrenia
Interventions: Drug: Org 24448;   Other: Placebo

Study has passed its completion date and status has not been verified in more than two years.